Hematologic Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
01 01 2022
Historique:
accepted: 24 09 2021
entrez: 31 12 2021
pubmed: 1 1 2022
medline: 23 2 2022
Statut: ppublish

Résumé

Studies of organ dysfunction in children are limited by a lack of consensus around organ dysfunction criteria. To derive evidence-informed, consensus-based criteria for hematologic dysfunction in critically ill children. Data sources included PubMed and Embase from January 1992 to January 2020. Studies were included if they evaluated assessment/scoring tools to screen for hematologic dysfunction and assessed outcomes of mortality, functional status, organ-specific outcomes, or other patient-centered outcomes. Studies of adults or premature infants, animal studies, reviews/commentaries, small case series, and non-English language studies with inability to determine eligibility were excluded. Data were abstracted from each eligible study into a standard data extraction form along with risk of bias assessment. Twenty-nine studies were included. The systematic review supports the following criteria for hematologic dysfunction: thrombocytopenia (platelet count <100000 cells/µL in patients without hematologic or oncologic diagnosis, platelet count <30000 cells/µL in patients with hematologic or oncologic diagnoses, or platelet count decreased ≥50% from baseline; or leukocyte count <3000 cells/µL; or hemoglobin concentration between 5 and 7 g/dL (nonsevere) or <5 g/dL (severe). Most studies evaluated pre-specified thresholds of cytopenias. No studies addressed associations between the etiology or progression of cytopenias overtime with outcomes, and no studies evaluated cellular function. Hematologic dysfunction, as defined by cytopenia, is a risk factor for poor outcome in critically ill children, although specific threshold values associated with increased mortality are poorly defined by the current literature.

Identifiants

pubmed: 34970675
pii: 184282
doi: 10.1542/peds.2021-052888K
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S74-S78

Investigateurs

Melania M Bembea (MM)
Michael Agus (M)
Ayse Akcan-Arikan (A)
Peta Alexander (P)
Rajit Basu (R)
Tellen D Bennett (TD)
Desmond Bohn (D)
Leonardo R Brandão (LR)
Ann-Marie Brown (AM)
Joseph A Carcillo (JA)
Paul Checchia (P)
Ira M Cheifetz (IM)
Timothy Cornell (T)
Michelle Eckerle (M)
Simon Erickson (S)
Reid W D Farris (RWD)
E Vincent S Faustino (EVS)
Julie C Fitzgerald (JC)
Dana Y Fuhrman (DY)
John S Giuliano (JS)
Kristin Guilliams (K)
Michael Gaies (M)
Stephen M Gorga (SM)
Mark Hall (M)
Sheila J Hanson (SJ)
Mary Hartman (M)
Amanda B Hassinger (AB)
Sharon Y Irving (SY)
Howard Jeffries (H)
Philippe Jouvet (P)
Sujatha Kannan (S)
Oliver Karam (O)
Robinder G Khemani (RG)
Niranjan Kissoon (N)
Jacques Lacroix (J)
Peter Laussen (P)
Francis Leclerc (F)
Jan Hau Lee (JH)
Stephane Leteurtre (S)
Katie Lobner (K)
Patrick J McKiernan (PJ)
Kusum Menon (K)
Paul Monagle (P)
Folafoluwa Odetola (F)
Nazima Pathan (N)
Richard W Pierce (RW)
Jose Pineda (J)
Jose M Prince (JM)
Karen A Robinson (KA)
Courtney M Rowan (CM)
Lindsay M Ryerson (LM)
L Nelson Sanchez-Pinto (LN)
Luregn J Schlapbach (LJ)
David T Selewski (DT)
Lara S Shekerdemian (LS)
Dennis Simon (D)
Lincoln S Smith (LS)
James E Squires (JE)
Robert H Squires (RH)
Scott M Sutherland (SM)
Yves Ouellette (Y)
Michael C Spaeder (MC)
Vijay Srinivasan (V)
Robert C Tasker (RC)
Ravi Thiagarajan (R)
Neal Thomas (N)
Pierre Tissieres (P)
Chani Traube (C)
Katri V Typpo (KV)
Mark S Wainwright (MS)
Shan L Ward (SL)
R Scott Watson (RS)
Scott Weiss (S)
Jane Whitney (J)
Doug Willson (D)
James L Wynn (JL)
Nadir Yehya (N)
Jerry J Zimmerman (JJ)

Informations de copyright

Copyright © 2022 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.

Auteurs

Jennifer A Muszynski (JA)

Department of Pediatrics, Critical Care Medicine, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio.

Jill M Cholette (JM)

Department of Pediatrics, Critical Care Medicine, University of Rochester, Rochester, New York.

Marie E Steiner (ME)

Department of Pediatrics, Critical Care Medicine & Hematology, University of Minnesota, Minneapolis, Minnesota.

Marisa Tucci (M)

Department of Pediatrics, Critical Care Medicine, CHU Sainte Justine, University of Montreal, Montreal, QC, Canada.

Allan Doctor (A)

Department of Pediatrics, Critical Care Medicine & Center for Blood Oxygen Transport and Hemostasis, University of Maryland, Baltimore, Maryland.

Robert I Parker (RI)

Department of Pediatrics, Hematology/Oncology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH